Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Opus Genetics (IRD) Other Gross PP&E Adjustments (2019 - 2026)

Opus Genetics has reported Other Gross PP&E Adjustments over the past 12 years, most recently at -$1.2 million for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 69.31% to -$1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.8 million through Mar 2026, up 43.08% year-over-year, with the annual reading at -$420000.0 for FY2025, 79.36% up from the prior year.
  • Other Gross PP&E Adjustments was -$1.2 million for Q1 2026 at Opus Genetics, down from -$420000.0 in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$79000.0 in Q2 2022 and troughed at -$4.1 million in Q1 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$948000.0 (2024), against an average of -$1.2 million.
  • Year-over-year, Other Gross PP&E Adjustments plummeted 1108.62% in 2024 and then skyrocketed 79.36% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.1 million in 2022, then tumbled by 60.6% to -$1.8 million in 2023, then dropped by 12.43% to -$2.0 million in 2024, then skyrocketed by 79.36% to -$420000.0 in 2025, then tumbled by 197.38% to -$1.2 million in 2026.
  • Per Business Quant, the three most recent readings for IRD's Other Gross PP&E Adjustments are -$1.2 million (Q1 2026), -$420000.0 (Q4 2025), and -$856000.0 (Q3 2025).